Utilizing patient navigators to enhance oral chemotherapy education and safety for at-risk patients.

Authors

null

Mingqian Lin

Tufts Medical Center, Boston, MA

Mingqian Lin, Douglas W Hackenyos, Daqin Mao, Feng Qing Wang, John Kalil Erban, Susan K. Parsons

Organizations

Tufts Medical Center, Boston, MA

Research Funding

Other Foundation

Background: Oral anticancer drugs are increasingly being used as standard therapy. At Tufts Medical Center Cancer Center, 10% of patients on active cancer treatment are receiving oral chemotherapy. To address barriers to medication education and timely management of treatment effects, we began an initiative involving our pharmacy specialist who reviews newly-started oral chemotherapy treatments for safety concerns, dose appropriateness, and drug interactions. In response to the cultural-linguistic needs of our Chinese patients (20% of our patients, largest minority group) and unique challenges of our patients of lower SES (40% of our patients), we are also leveraging patient navigators (PN) to improve timely care and understanding of and adherence to oral cancer medications for our most vulnerable patients. Methods: PN regularly interact with patients and work closely with the care team to address patients’ concerns. Formal PN visits with patients in clinic are documented in the EMR. To assess the scope of issues related to oral chemotherapy and/or supportive care drugs (e.g. anti-nausea, anti-constipation) and the potential impact in using PN, we reviewed PN encounter notes from the first 6 months of 2016 to identify patient-reported issues. Results: In reviewing 492 PN encounter notes from the first 6 months of 2016 (111 patients were navigated), 138 (28%) of all patient encounters involved assistance related to oral chemotherapy, supportive care drugs, and/or comorbidities medications. Examples of patient-reported issues include confusion about purpose and/or type of drug, dosing scheduling, side effects management, and logistical challenges (e.g. refills, copays, specialty pharmacy orders). Conclusions: From the PN encounter notes, we identified a need for more formalized patient-centered interventions to enhance education, monitoring, and patient-provider communication about oral chemotherapy to proactively resolve medication-related issues. We are piloting an evidence-based approach involving pharmacist-PN-patient teaching sessions, tailored patient education tools, and scheduled check-ins between PN and patients adapted from the MASCC Oral Agent Teaching Tool model.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2017 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B: Patient Safety and Science of Quality

Track

Patient Safety,Science of Quality

Sub Track

Incorporating High Reliability Principles and Tools Into Patient Safety Programs

Citation

J Clin Oncol 35, 2017 (suppl 8S; abstract 43)

DOI

10.1200/JCO.2017.35.8_suppl.43

Abstract #

43

Poster Bd #

A11

Abstract Disclosures

Similar Abstracts

First Author: Audrea H Szabatura

First Author: Analia Nguyen

First Author: Marina D. Kaymakcalan

Abstract

2023 ASCO Annual Meeting

Characterization of drug and non-drug interactions in patients treated in medical oncology.

First Author: Yacine-Abdallah Ghomari Jr.